Exosomes are a type of vesicles (Extracellular Vesicles, EVs) secreted by cells to the outside of the cell, with a size of 30-150nm, a double-layer membrane structure and a saucer-like shape, and rich contents (including nucleic acids, proteins and lipids, etc.), involved in the transfer of molecules between cells.
As an emerging technology, it has many problems, including accurately encoding and delivering targeted therapeutics, not to mention issues surrounding intellectual property and large-scale manufacturing. For diagnostic applications, products from Exosome Diagnostics are available; for therapeutic applications, although there are three listed companies focusing on exosomes - Capricor, Puretech and Reneuron, none of the company's products have actually been used in clinical practice.
This report aims to provide a comprehensive presentation of the global market for Msenchymal Stem Cell and Exosome Diagnostics and Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Msenchymal Stem Cell and Exosome Diagnostics and Therapies. This report contains market size and forecasts of Msenchymal Stem Cell and Exosome Diagnostics and Therapies in global, including the following market information:
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Exosome industry in China is in the initial stage of germination and development, The exosome industry in foreign currently has a limited number of players. Geographically speaking, China holds about 80% of total market share.
We surveyed the Msenchymal Stem Cell and Exosome Diagnostics and Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Segment Percentages, by Type, 2022 (%)
Type I
Type II
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Segment Percentages, by Application, 2022 (%)
Diagnostics
Therapies
Skincare
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Msenchymal Stem Cell and Exosome Diagnostics and Therapies revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Msenchymal Stem Cell and Exosome Diagnostics and Therapies revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Tianjin Angsai Cell Genetic Engineering Co. Ltd
Qingdao Aoke Biological Development Co. Ltd
Beijing SH biotechnology Co. Ltd
Beijing Beilai Biotechnology Co. Ltd
Shanghai Aisar Biotechnology Co. Ltd
Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
Beijing Han's United Biotechnology Co. Ltd
Bosheng Excellence Biotechnology (Beijing) Co. Ltd
Cellular Biomedicine Group
Guangzhou Celera Stem Cell Technology Co. Ltd.
Stem Med Pte Ltd
CryoCord Sdn Bhd
Cytopeutics Sdn Bhd
Stempeutics Research Pvt Ltd
Asian Institute of Gastroenterology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Msenchymal Stem Cell and Exosome Diagnostics and Therapies, market overview.
Chapter 2: Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market size in revenue.
Chapter 3: Detailed analysis of Msenchymal Stem Cell and Exosome Diagnostics and Therapies company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Msenchymal Stem Cell and Exosome Diagnostics and Therapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Overall Market Size
2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size: 2022 VS 2029
2.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players in Global Market
3.2 Top Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies Ranked by Revenue
3.3 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue by Companies
3.4 Top 3 and Top 5 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies in Global Market, by Revenue in 2022
3.5 Global Companies Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players in Global Market
3.6.1 List of Global Tier 1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies
3.6.2 List of Global Tier 2 and Tier 3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Markets, 2022 & 2029
4.1.2 Type I
4.1.3 Type II
4.2 By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue & Forecasts
4.2.1 By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2018-2023
4.2.2 By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2024-2029
4.2.3 By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2022 & 2029
5.1.2 Diagnostics
5.1.3 Therapies
5.1.4 Skincare
5.2 By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue & Forecasts
5.2.1 By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2018-2023
5.2.2 By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2024-2029
5.2.3 By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2022 & 2029
6.2 By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue & Forecasts
6.2.1 By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2018-2023
6.2.2 By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2024-2029
6.2.3 By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2018-2029
6.3.2 US Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.3.3 Canada Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.3.4 Mexico Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2018-2029
6.4.2 Germany Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.4.3 France Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.4.4 U.K. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.4.5 Italy Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.4.6 Russia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.4.7 Nordic Countries Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.4.8 Benelux Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2018-2029
6.5.2 China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.5.3 Japan Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.5.4 South Korea Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.5.5 Southeast Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.5.6 India Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2018-2029
6.6.2 Brazil Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.6.3 Argentina Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2018-2029
6.7.2 Turkey Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.7.3 Israel Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.7.4 Saudi Arabia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
6.7.5 UAE Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2018-2029
7 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies Profiles
7.1 Tianjin Angsai Cell Genetic Engineering Co. Ltd
7.1.1 Tianjin Angsai Cell Genetic Engineering Co. Ltd Company Summary
7.1.2 Tianjin Angsai Cell Genetic Engineering Co. Ltd Business Overview
7.1.3 Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.1.4 Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2018-2023)
7.1.5 Tianjin Angsai Cell Genetic Engineering Co. Ltd Key News & Latest Developments
7.2 Qingdao Aoke Biological Development Co. Ltd
7.2.1 Qingdao Aoke Biological Development Co. Ltd Company Summary
7.2.2 Qingdao Aoke Biological Development Co. Ltd Business Overview
7.2.3 Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.2.4 Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2018-2023)
7.2.5 Qingdao Aoke Biological Development Co. Ltd Key News & Latest Developments
7.3 Beijing SH biotechnology Co. Ltd
7.3.1 Beijing SH biotechnology Co. Ltd Company Summary
7.3.2 Beijing SH biotechnology Co. Ltd Business Overview
7.3.3 Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.3.4 Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2018-2023)
7.3.5 Beijing SH biotechnology Co. Ltd Key News & Latest Developments
7.4 Beijing Beilai Biotechnology Co. Ltd
7.4.1 Beijing Beilai Biotechnology Co. Ltd Company Summary
7.4.2 Beijing Beilai Biotechnology Co. Ltd Business Overview
7.4.3 Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.4.4 Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2018-2023)
7.4.5 Beijing Beilai Biotechnology Co. Ltd Key News & Latest Developments
7.5 Shanghai Aisar Biotechnology Co. Ltd
7.5.1 Shanghai Aisar Biotechnology Co. Ltd Company Summary
7.5.2 Shanghai Aisar Biotechnology Co. Ltd Business Overview
7.5.3 Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.5.4 Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2018-2023)
7.5.5 Shanghai Aisar Biotechnology Co. Ltd Key News & Latest Developments
7.6 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
7.6.1 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Company Summary
7.6.2 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Business Overview
7.6.3 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.6.4 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2018-2023)
7.6.5 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Key News & Latest Developments
7.7 Beijing Han's United Biotechnology Co. Ltd
7.7.1 Beijing Han's United Biotechnology Co. Ltd Company Summary
7.7.2 Beijing Han's United Biotechnology Co. Ltd Business Overview
7.7.3 Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.7.4 Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2018-2023)
7.7.5 Beijing Han's United Biotechnology Co. Ltd Key News & Latest Developments
7.8 Bosheng Excellence Biotechnology (Beijing) Co. Ltd
7.8.1 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Company Summary
7.8.2 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Business Overview
7.8.3 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.8.4 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2018-2023)
7.8.5 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Key News & Latest Developments
7.9 Cellular Biomedicine Group
7.9.1 Cellular Biomedicine Group Company Summary
7.9.2 Cellular Biomedicine Group Business Overview
7.9.3 Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.9.4 Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2018-2023)
7.9.5 Cellular Biomedicine Group Key News & Latest Developments
7.10 Guangzhou Celera Stem Cell Technology Co. Ltd.
7.10.1 Guangzhou Celera Stem Cell Technology Co. Ltd. Company Summary
7.10.2 Guangzhou Celera Stem Cell Technology Co. Ltd. Business Overview
7.10.3 Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.10.4 Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2018-2023)
7.10.5 Guangzhou Celera Stem Cell Technology Co. Ltd. Key News & Latest Developments
7.11 Stem Med Pte Ltd
7.11.1 Stem Med Pte Ltd Company Summary
7.11.2 Stem Med Pte Ltd Business Overview
7.11.3 Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.11.4 Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2018-2023)
7.11.5 Stem Med Pte Ltd Key News & Latest Developments
7.12 CryoCord Sdn Bhd
7.12.1 CryoCord Sdn Bhd Company Summary
7.12.2 CryoCord Sdn Bhd Business Overview
7.12.3 CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.12.4 CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2018-2023)
7.12.5 CryoCord Sdn Bhd Key News & Latest Developments
7.13 Cytopeutics Sdn Bhd
7.13.1 Cytopeutics Sdn Bhd Company Summary
7.13.2 Cytopeutics Sdn Bhd Business Overview
7.13.3 Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.13.4 Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2018-2023)
7.13.5 Cytopeutics Sdn Bhd Key News & Latest Developments
7.14 Stempeutics Research Pvt Ltd
7.14.1 Stempeutics Research Pvt Ltd Company Summary
7.14.2 Stempeutics Research Pvt Ltd Business Overview
7.14.3 Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.14.4 Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2018-2023)
7.14.5 Stempeutics Research Pvt Ltd Key News & Latest Developments
7.15 Asian Institute of Gastroenterology
7.15.1 Asian Institute of Gastroenterology Company Summary
7.15.2 Asian Institute of Gastroenterology Business Overview
7.15.3 Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.15.4 Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2018-2023)
7.15.5 Asian Institute of Gastroenterology Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Opportunities & Trends in Global Market
Table 2. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Drivers in Global Market
Table 3. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Restraints in Global Market
Table 4. Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies in Global Market
Table 5. Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Share by Companies, 2018-2023
Table 8. Global Companies Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Type
Table 9. List of Global Tier 1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2024-2029
Table 30. Tianjin Angsai Cell Genetic Engineering Co. Ltd Company Summary
Table 31. Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 32. Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn) & (2018-2023)
Table 33. Tianjin Angsai Cell Genetic Engineering Co. Ltd Key News & Latest Developments
Table 34. Qingdao Aoke Biological Development Co. Ltd Company Summary
Table 35. Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 36. Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn) & (2018-2023)
Table 37. Qingdao Aoke Biological Development Co. Ltd Key News & Latest Developments
Table 38. Beijing SH biotechnology Co. Ltd Company Summary
Table 39. Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 40. Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn) & (2018-2023)
Table 41. Beijing SH biotechnology Co. Ltd Key News & Latest Developments
Table 42. Beijing Beilai Biotechnology Co. Ltd Company Summary
Table 43. Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 44. Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn) & (2018-2023)
Table 45. Beijing Beilai Biotechnology Co. Ltd Key News & Latest Developments
Table 46. Shanghai Aisar Biotechnology Co. Ltd Company Summary
Table 47. Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 48. Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn) & (2018-2023)
Table 49. Shanghai Aisar Biotechnology Co. Ltd Key News & Latest Developments
Table 50. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Company Summary
Table 51. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 52. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn) & (2018-2023)
Table 53. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Key News & Latest Developments
Table 54. Beijing Han's United Biotechnology Co. Ltd Company Summary
Table 55. Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 56. Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn) & (2018-2023)
Table 57. Beijing Han's United Biotechnology Co. Ltd Key News & Latest Developments
Table 58. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Company Summary
Table 59. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 60. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn) & (2018-2023)
Table 61. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Key News & Latest Developments
Table 62. Cellular Biomedicine Group Company Summary
Table 63. Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 64. Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn) & (2018-2023)
Table 65. Cellular Biomedicine Group Key News & Latest Developments
Table 66. Guangzhou Celera Stem Cell Technology Co. Ltd. Company Summary
Table 67. Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 68. Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn) & (2018-2023)
Table 69. Guangzhou Celera Stem Cell Technology Co. Ltd. Key News & Latest Developments
Table 70. Stem Med Pte Ltd Company Summary
Table 71. Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 72. Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn) & (2018-2023)
Table 73. Stem Med Pte Ltd Key News & Latest Developments
Table 74. CryoCord Sdn Bhd Company Summary
Table 75. CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 76. CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn) & (2018-2023)
Table 77. CryoCord Sdn Bhd Key News & Latest Developments
Table 78. Cytopeutics Sdn Bhd Company Summary
Table 79. Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 80. Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn) & (2018-2023)
Table 81. Cytopeutics Sdn Bhd Key News & Latest Developments
Table 82. Stempeutics Research Pvt Ltd Company Summary
Table 83. Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 84. Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn) & (2018-2023)
Table 85. Stempeutics Research Pvt Ltd Key News & Latest Developments
Table 86. Asian Institute of Gastroenterology Company Summary
Table 87. Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 88. Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn) & (2018-2023)
Table 89. Asian Institute of Gastroenterology Key News & Latest Developments
List of Figures
Figure 1. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Segment by Type in 2022
Figure 2. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Segment by Application in 2022
Figure 3. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in 2022
Figure 8. By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2018-2029
Figure 9. By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2018-2029
Figure 10. By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2018-2029
Figure 12. By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2018-2029
Figure 14. By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2018-2029
Figure 15. By Country - North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2018-2029
Figure 16. US Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2018-2029
Figure 20. Germany Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 21. France Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2018-2029
Figure 28. China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 32. India Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2018-2029
Figure 34. Brazil Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2018-2029
Figure 37. Turkey Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2018-2029
Figure 41. Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
